Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain

• Published in: Biochemical and biophysical research communications 2008-02, Vol.366 (1), p.86-91
• Main Authors: Anagli, John, Abounit, Kadija, Stemmer, Paul, Han, Yuxia, Allred, Lisa, Weinsheimer, Shantel, Movsisyan, Ashkhen, Seyfried, Donald
• Format: Article
• Language: English
• Subjects: Adaptation, Physiological; Albumin; Animals; Brain Ischemia - metabolism; Cathepsin B; Cathepsin B - antagonists & inhibitors; Cathepsin B - metabolism; Cathepsin L; Cathepsins - antagonists & inhibitors; Cathepsins - metabolism; Cysteine Endopeptidases - metabolism; Heat-Shock Proteins - metabolism; Male; Middle cerebral artery occlusion; Nerve Tissue Proteins - metabolism; Neuroprotection; Protease inhibitor; Rat; Rats; Rats, Wistar
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2007.11.104

The effects of selective inhibition of cathepsins B and L on postischemic protein alterations in the brain were investigated in a rat model of middle cerebral artery occlusion (MCAO). Cathepsin B activity increased predominantly in the subcortical region of the ischemic hemisphere where the levels of collapsing mediator response protein 2, heat shock cognate 70kDa protein, 60kDa heat shock protein, protein disulfide isomerase A3 and albumin, were found to be significantly elevated. Postischemic treatment with Cbz-Phe-Ser(OBzl)-CHN2, cysteine protease inhibitor 1 (CP-1), reduced infarct volume, neurological deficits and cathepsin B activity as well as the amount of heat shock proteins and albumin found in the brain. Our data strongly suggests that the decrease in heat shock protein levels and the significant reduction of serum albumin leakage into the brain following acute treatment with CP-1 is indicative of less secondary ischemic damage, which ultimately, is related to less cerebral tissue loss and improved neurological recovery of the animals.